Antinociceptive Action of Cholinomimetics Evaluated with the Method of the Return of Corneal Anesthesia Induced with Procaine

  • F. Aloisi
  • A. Scotti de Carolis
  • V. G. Longo
Part of the Advances in Behavioral Biology book series (ABBI, volume 25)


The antinociceptive action of cholinomimetic agents has been extensively described in the literature using a variety of methods involving mechanical, termal or chemical stimulation. Tremorine, a cholinomimetic drug with tremorogenic activity, suppresses the responsiveness of mice to tail pinching (3). Arecoline shows an antinociceptive action in the tooth pulp test in the rabbit and in several tests in mice and rats (vocalization response, tail flick, tail pinching, hot plate, abdominal writhing)(8). Eserine and oxotremorine are active in the tail flick test in mice (4). Cholinomimetic show antinociceptive activity also when injected into the cerebral ventricles, or into various cerebral areas. This has been demonstrated by Metys et al. (8) for carbachol and oxotremorine and by Pedigo et al. (9) for acetylcholine (ACh). The antinociceptive action of cholinomimetics is abolished by atropine or by other anticholinergic drugs but is not influenced by methyl-atropine. According to some authors, narcotic antagonists also are able to oppose this effect of cholinergics (4,9).


Antinociceptive Effect Cerebral Ventricle Antinociceptive Action Tail Flick Tail Flick Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aloisi, F. and Scötti de Carolis, A. (1980): Israel J. Med. Sci. (in press).Google Scholar
  2. 2.
    Carrol, M.N. Jr. and Lim, R.K.S. (1960): Arch. Int. Pharmacodyn. 125:383–403.Google Scholar
  3. 3.
    Chen, G. (1958): J. Pharmacol. Exp. Ther. 124:73–76.Google Scholar
  4. 4.
    Harris, L.S., Dewey, W.L., Howes, J.F., Kennedy, J.S. and Pars, H. (1969): J. Pharmacol. Exp. Ther. 169:17–22.Google Scholar
  5. 5.
    Ireson, J.D. (1970): Brit. J. Pharmacol. 40:92–101.CrossRefGoogle Scholar
  6. 6.
    Karczmar, A.G. (1977): IN Cholinergic Mechanisms and Psychopharmacology (ed) D.J. Jenden, Plenum Press, New York, pp. 679–708.Google Scholar
  7. 7.
    Keil, W. and Pohls, F.H. (1936): Arch. Exp. Pathol. Pharmacol. 181:285–291.CrossRefGoogle Scholar
  8. 8.
    Metys, J., Wayner, N., Metysova, J. and Herz, A. (1969): Int. J. Neuropharmacol. 8:413–425.CrossRefGoogle Scholar
  9. 9.
    Pedigo, N.W., Dewey, W.L. and Harris, L.S. (1975): J. Pharmacol. Exp. Ther. 193:845–852.Google Scholar
  10. 10.
    Regneir, M.J. (1923): CR. Soc. Biol. Paris 77:558–560.Google Scholar

Copyright information

© Plenum Press, New York 1981

Authors and Affiliations

  • F. Aloisi
    • 1
  • A. Scotti de Carolis
    • 1
  • V. G. Longo
    • 1
  1. 1.Laboratorio di FarmacologiaIstituto Superiore di SanitaRomeItaly

Personalised recommendations